Order Article Reprints

Mistretta FA, Luzzago S, Conti A, Verri E, Marvaso G, Collà Ruvolo C, Catellani M, Di Trapani E, Cozzi G, Bianchi R, et al. Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone. Cancers. 2022; 14(9):2313. https://doi.org/10.3390/cancers14092313

Mistretta, Francesco A., Stefano Luzzago, Andrea Conti, Elena Verri, Giulia Marvaso, Claudia Collà Ruvolo, Michele Catellani, Ettore Di Trapani, Gabriele Cozzi, Roberto Bianchi, and et al. 2022. "Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone" Cancers 14, no. 9: 2313. https://doi.org/10.3390/cancers14092313

Mistretta, F. A., Luzzago, S., Conti, A., Verri, E., Marvaso, G., Collà Ruvolo, C., Catellani, M., Di Trapani, E., Cozzi, G., Bianchi, R., Ferro, M., Cordima, G., Brescia, A., Cossu Rocca, M., Mirone, V., Jereczek-Fossa, B. A., Nolè, F., de Cobelli, O., & Musi, G. (2022). Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone. Cancers, 14(9), 2313. https://doi.org/10.3390/cancers14092313